# A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea

> **NCT07497854** · — · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 3000 (estimated)

## Conditions studied

- Migraine With or Without Aura

## Interventions

- **DRUG:** Rimegepant sulfate

## Key facts

- **NCT ID:** NCT07497854
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2030-07-31
- **Final completion:** 2030-08-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07497854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07497854, "A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT07497854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*